Time-varying hazard ratios are popular tools to evaluate how vaccine effects vary over time. We explore how to use negative control infections to remove inherent bias in these estimates.
Recommended citation: Ashby, Ethan, et al. (2025). "Debiasing hazard-based, time-varying vaccine effects using vaccine-irrelevant infections: An observational extension of a pivotal Phase 3 COVID-19 vaccine efficacy trial." ArXiv. https://arxiv.org/abs/2511.15099
Published in American Journal of Epidemiology, 2025
Irrelevant infection endpoints confirmed as a valid negative control for COVID-19 and are leveraged to detect bias in hazard-based, time-varying vaccine efficacy estimates.
Adjustment for off-target endpoints can improve the efficiency of early-phase randomized trials.
Recommended citation: Ashby, Ethan, et al. (2025). "Negative Control Outcome Adjustment in Early-Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants." Statistics in Medicine. https://onlinelibrary.wiley.com/doi/10.1002/sim.70142
Investigating time-course transcriptional response to Bdf3 inhibition in the parasite that causes sleeping sickness.
Recommended citation: Ashby, Ethan C. (2023). "Chemical Inhibition of Bromodomain Proteins in Insect-Stage African Trypanosomes Perturbs Silencing of the Variant Surface Glycoprotein Repertoire and Results in Widespread Changes in the Transcriptome." Microbiology Spectrum. 1(1). https://journals.asm.org/doi/full/10.1128/spectrum.00147-23
Cut&Run data analysis demonstrates Bdf3 protein occupancy changes at different sites on the T. brucei genome.
Recommended citation: Ashby, Ethan, et al. (2022). "Genomic Occupancy of the Bromodomain Protein Bdf3 Is Dynamic during Differentiation of African Trypanosomes from Bloodstream to Procyclic Forms." MSphere . 7(3). https://journals.asm.org/doi/full/10.1128/msphere.00023-22